CodeRunner
Therapeutics Research & Development
1. What makes developing a therapeutic for dogs different from for humans?
The canine immune system, metabolism, and disease pathologies have distinct differences from humans. A successful canine therapeutic requires species-specific reagents, particularly for biologics, to ensure efficacy and avoid adverse immune reactions. Our services are built around this principle, focusing entirely on canine-specific models and platforms.
2. How does an integrated service accelerate my project compared to using separate vendors?
An integrated platform eliminates logistical hurdles, reduces sample shipping risks, and ensures data continuity. Knowledge transfer between discovery, in vitro, and in vivo teams is seamless, preventing costly delays and rework. This streamlined process shortens the overall project timeline from concept to candidate.
No results for "Therapeutics Research & Development"